Pricing Log in Create free account

iBio, Inc. (IBIO) vs Mereo BioPharma Group plc - Sponsored ADR (MREO)

iBio, Inc. and Mereo BioPharma Group plc - Sponsored ADR are both Biotechnology companies. iBio, Inc. and Mereo BioPharma Group plc - Sponsored ADR are of similar size ($49.3M and $47.6M). Across the 9 metrics below, iBio, Inc. leads on 8 and Mereo BioPharma Group plc - Sponsored ADR on 1.

Valuation

Metric IBIO MREO Biotechnology median
P/E n/m n/m 8.50
P/S 118.71 n/m 9.71
P/B 0.93 1.68 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.19 n/m 0.64
EV/Sales (9.70) n/m 9.21
Earnings yield (44.16%) (58.20%) (33.15%)
Free cash flow yield (30.24%) (53.23%) (25.50%)

Profitability

Metric IBIO MREO Biotechnology median
Gross margin 100.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (65.70%) (67.85%) (56.36%)
Return on assets (54.04%) (57.73%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric IBIO MREO Biotechnology median
Revenue growth (TTM) (66.55%) — 6.02%
EPS growth (last fiscal year) 81.71% 10.16% 30.26%
Revenue growth, 5-year CAGR (42.83%) — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric IBIO MREO Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 7.85 5.88 4.72
Net debt to EBITDA 2.57 1.04 0.96

Dividend

Metric IBIO MREO Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric IBIO MREO Biotechnology median
Market cap 47.63m 49.34m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack